P-107 Efficacy of 2nd-line ramucirumab (RAM) plus FOLFIRI for RAS wild-type metastatic colorectal cancer (mCRC) by prior regimen: Subgroup analysis of the JACCRO CC-16

Y. Okita, A. Tsuji,T. Watanabe, H. Satake,M. Goto, H. Yasui,M. Nakamura,T. Sagawa,K. Kataoka,M. Shiozawa,Y. Sunakawa, H. Ota,M. Kotaka,K. Miwa,Y. Kobayashi, H. Okuyama,M. Kochi, T. Masuishi, M. Takeuchi, W. Ichikawa

ANNALS OF ONCOLOGY(2022)

引用 1|浏览14
暂无评分
关键词
metastatic colorectal cancer,colorectal cancer,nd-line,wild-type
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要